^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

KRC-108

i
Other names: KRC-108
News
Trials
Company:
Korea Research Institute of Chemical Technology
Drug class:
TrkA receptor inhibitor, c-MET inhibitor, FLT3 inhibitor, Aurora kinase A inhibitor, RON inhibitor
Related drugs:
News
Trials